- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00741962
A Study on the Effects of VR-3 Herbal Blend Intake on Acute and Chronic Stress in Healthy Adults
May 11, 2009 updated by: NEMA Research, Inc.
A Pilot Double-Blind Crossover Study on the Effects of VR-3 Herbal Blend Intake on Acute and Chronic Stress and Their Biomarkers in Healthy Adults
The purpose of this study is to determine the safety and efficacy of VR-3 Herbal Blend and its effects on acute and chronic stress responses.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Naples, Florida, United States, 34108
- NEMA Research
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
35 years to 45 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Men and women between the ages of 35-45
- No health concerns as determined by study physicians
- Women must not be pregnant or become pregnant for the duration of the study.
Exclusion Criteria:
- The subject has a history of hypersensitivity to any of the compounds used in the study
- The subject is pregnant or a lactating female. Note: If the potential subject is a post-menarcheal female, a pregnancy test (urine or serum) must be performed within 24 hours of study drug administration and confirmed negative in order for the potential subject to be enrolled).
- History of Psychiatric Illness or Chronic Stress or Anxiety
- Hypertension, cardiovascular disease, or other health concerns that may confound study results
- Allergy or sensitivity to test product or ingredients
- Individuals who are cognitively impaired or who are not able to give informed consent
- Clinically significant or abnormal laboratory result that can confound the study
- Medication or nutraceutical intake that can interact with the adaptogens or the biomarkers used in the study (to be determined by study physician)
- Previous participation in a clinical research trial within 30 days prior to randomization
- The subject has an ongoing abuse of illicit substances, alcohol, or actively smoking marijuana.
- The subject is actively engaging in the use of Herbal Medicine, Traditional Chinese Medicine, Ancient Indian Medicine, Yoga, or Ayurveda
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: 1
|
This is a liquid blend of various reputed adaptogenic herbs.
The dosage will be 2ml of liquid per day.
|
|
Placebo Comparator: 2
|
The placebo will be a similar tasting liquid as VR-3 Herbal blend.
The dosage will be 2ml of liquid per day.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in salivary alpha-amylase and cortisol as stress biomarkers for the acute and chronic stress response following VR-3 Herbal Blend use
Time Frame: 10 weeks
|
10 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in acute psychological stress
Time Frame: 10 weeks
|
10 weeks
|
|
Change in chronic stress
Time Frame: 10 weeks
|
10 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2008
Primary Completion (Actual)
April 1, 2009
Study Completion (Actual)
April 1, 2009
Study Registration Dates
First Submitted
August 25, 2008
First Submitted That Met QC Criteria
August 25, 2008
First Posted (Estimate)
August 26, 2008
Study Record Updates
Last Update Posted (Estimate)
May 12, 2009
Last Update Submitted That Met QC Criteria
May 11, 2009
Last Verified
May 1, 2009
More Information
Terms related to this study
Other Study ID Numbers
- Adaptogen Study 001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.